Literature DB >> 18474310

Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion?

Chun-Ta Liao1, Joseph Tung-Chieh Chang, Hung-Ming Wang, Shu-Hang Ng, Chuen Hsueh, Li-Yu Lee, Chih-Hung Lin, I-How Chen, Shiang-Fu Huang, Ann-Joy Cheng, Lai-Chu See, Tzu-Chen Yen.   

Abstract

PURPOSE: The criteria for administration of adjuvant radiation therapy (RT) in oral cavity squamous cell carcinoma (OSCC) remain controversial, and it is unclear whether patients with pT1-3N0 disease benefit from adjuvant radiation in the presence of free margins and perineural invasion. The goal of this report was to determine whether this group would benefit from adjuvant radiation therapy in terms of 5-year local control rate and overall survival rate. METHODS AND MATERIALS: We retrospectively reviewed our case records from January 1996 to May 2005. In all, 460 pT1-3N0 OSCC patients had tumor-free margins, of whom 68 had perineural invasion. Postoperative adjuvant RT was performed in patients with pT4 tumors, positive lymph nodes, or close margins (< or =4 mm). In addition, selected OSCC patients with large pT3 tumors or perineural invasion received postoperative adjuvant RT. Local control and overall survival rates were plotted by Kaplan-Meier analysis.
RESULTS: There were no significant differences in 5-year local control (p = 0.1936) and overall survival (p = 0.5580) rates between patients with perineural invasion compared with those without. Among patients with perineural invasion, the addition of adjuvant radiotherapy did not significantly alter the 5-year local control rate (p = 0.3170) or the overall survival rate (p = 0.0935).
CONCLUSION: Altogether, these data seem to indicate that radical surgical resection alone should be considered a sufficient treatment for OSCC patients with pT1-3N0 disease, even in the presence of perineural invasion.

Entities:  

Mesh:

Year:  2008        PMID: 18474310     DOI: 10.1016/j.ijrobp.2007.10.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy.

Authors:  Matthias Kreppel; Uta Drebber; Hans-Theodor Eich; Timo Dreiseidler; Joachim E Zöller; Rolf-Peter Müller; Martin Scheer
Journal:  Strahlenther Onkol       Date:  2011-03-14       Impact factor: 3.621

2.  Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma.

Authors:  Steven B Chinn; Matthew E Spector; Emily L Bellile; Jonathan B McHugh; Thomas J Gernon; Carol R Bradford; Gregory T Wolf; Avraham Eisbruch; Douglas B Chepeha
Journal:  Otolaryngol Head Neck Surg       Date:  2013-10-23       Impact factor: 3.497

Review 3.  Intraoperative Margin Assessment in Head and Neck Cancer: A Case of Misuse and Abuse?

Authors:  Mark W Kubik; Shaum Sridharan; Mark A Varvares; Dan P Zandberg; Heath D Skinner; Raja R Seethala; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2020-03-02

Review 4.  Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.

Authors:  Dante De Paz; Huang-Kai Kao; Yenlin Huang; Kai-Ping Chang
Journal:  Curr Oncol Rep       Date:  2017-08-10       Impact factor: 5.075

5.  A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma.

Authors:  Phillip Huyett; Mark Gilbert; Lijun Liu; Robert L Ferris; Seungwon Kim
Journal:  J Vis Exp       Date:  2017-01-05       Impact factor: 1.355

Review 6.  Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem.

Authors:  Moran Amit; Ayelet Eran; Salem Billan; Eran Fridman; Shorook Na'ara; Tomer Charas; Ziv Gil
Journal:  J Neurol Surg B Skull Base       Date:  2016-02-26

7.  Defining the Prevalence and Prognostic Value of Perineural Invasion and Angiolymphatic Invasion in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Authors:  William G Albergotti; Hannah L Schwarzbach; Shira Abberbock; Robert L Ferris; Jonas T Johnson; Umamaheswar Duvvuri; Seungwon Kim
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

8.  Prospective study on factors affecting the prognosis of oral cancer in a Chinese population.

Authors:  Fengqiong Liu; Fa Chen; Jiangfeng Huang; Lingjun Yan; Fangping Liu; Junfeng Wu; Yu Qiu; Xiaoyan Zheng; Rongzhao Zhang; Lisong Lin; Baochang He
Journal:  Oncotarget       Date:  2017-01-17

Review 9.  Oral cancer: Current role of radiotherapy and chemotherapy.

Authors:  Shao-Hui Huang; Brian O'Sullivan
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01

10.  Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.

Authors:  Anthony C Nichols; John Yoo; J Alex Hammond; Kevin Fung; Eric Winquist; Nancy Read; Varagur Venkatesan; S Danielle MacNeil; D Scott Ernst; Sara Kuruvilla; Jeff Chen; Martin Corsten; Michael Odell; Libni Eapen; Julie Theurer; Philip C Doyle; Bret Wehrli; Keith Kwan; David A Palma
Journal:  BMC Cancer       Date:  2013-03-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.